Ironwood Pharmaceuticals Ownership | Who Owns Ironwood Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Ironwood Pharmaceuticals Ownership Summary


Ironwood Pharmaceuticals is owned by 98.65% institutional investors, 2.93% insiders. Blackrock is the largest institutional shareholder, holding 14.51% of IRWD shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.66% of its assets in Ironwood Pharmaceuticals shares.

IRWD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockIronwood Pharmaceuticals98.65%2.93%-1.58%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.67%13.90%65.43%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock22.88M14.51%$149.16M
Vanguard group15.96M9.84%$53.78M
Armistice capital15.03M9.26%$52.75M
Blackrock funding, inc. /de13.36M8.24%$46.90M
Sarissa capital management lp9.19M5.66%$32.25M
Renaissance8.06M4.97%$28.29M
Aqr capital management7.54M4.65%$26.45M
State street7.46M4.60%$26.17M
Acadian asset management6.58M4.05%$23.07M
Two sigma investments, lp5.85M3.61%$20.53M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sarissa capital management lp9.19M20.46%$32.25M
Cm management350.00K1.03%$1.23M
Armistice capital15.03M0.94%$52.75M
Kynam capital management, lp5.47M0.53%$7.16M
Range financial group433.26K0.51%$1.52M
Integrated quantitative investments552.10K0.35%$1.94M
Harvest investment services241.88K0.16%$849.00K
Inspire investing509.94K0.15%$1.79M
Optimist retirement group94.83K0.15%$332.86K
Gsa capital partners llp654.45K0.14%$2.30M

Top Buyers

HolderShares% AssetsChange
State street7.46M0.00%3.05M
Two sigma investments, lp5.85M0.02%3.00M
Arrowstreet capital, limited partnership3.40M0.01%2.99M
Aqr capital management7.54M0.01%2.81M
Dimensional fund advisors lp2.08M0.00%1.75M

Top Sellers

HolderShares% AssetsChange
Sarissa capital management lp9.19M20.46%-6.73M
Braidwell lp---6.62M
Brown capital management---2.58M
Jane street group622.25K0.00%-2.20M
Pacer advisors---1.79M

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust988.63K0.00%988.63K$3.47M
Vanguard global advisers591.49K0.00%591.49K$2.08M
Wedge capital management l l p/nc540.49K0.04%540.49K$1.90M
Inspire investing509.94K0.15%509.94K$1.79M
Bnp paribas asset management375.29K0.00%375.29K$1.32M

Sold Out

HolderChange
Natixis-2.00
Jfs wealth advisors-10.00
Mendota financial group-11.00
Dinuzzo private wealth-15.00
Nelson, van denburg & campbell wealth management group-26.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202623012.75%160,024,9363.50%981.09%13815.00%5414.89%
Dec 31, 2025151-10.12%107,820,680-27.61%660.78%85-2.30%38-13.64%
Sep 30, 20251608.84%148,842,9659.30%921.30%829.33%43-4.44%
Jun 30, 2025153-24.26%146,234,9095.06%901.21%76-27.62%49-20.97%
Mar 31, 2025201-11.45%155,281,777-5.40%960.91%104-11.86%62-18.42%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF9.06M5.66%-
State Street® SPDR® S&P® Biotech ETF4.43M2.69%-44.88K
Vanguard Total Stock Mkt Idx Inv4.33M2.63%-
Vanguard US Total Market Shares ETF4.18M2.59%-
iShares Russell 2000 ETF3.80M2.31%32.05K
Schwab Fundamental U.S. Small CompanyETF2.85M1.73%-
SPDR® S&P Biotech ETF2.51M1.57%-15.31K
Vanguard Strategic Equity Inv2.10M1.28%-343.65K
Vanguard Small Cap Index1.74M1.09%1.41K
Vanguard Explorer Inv1.63M0.99%-602.51K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 17, 2026DENNER ALEXANDER J-Sell$19.20K
Mar 17, 2026DENNER ALEXANDER J-Sell$20.51M
Feb 23, 2026John Minardo Chief Legal OfficerSell$66.44K
Feb 24, 2026John Minardo Chief Legal OfficerSell$69.73K
Feb 23, 2026Shetzline Michael SVP, CMO, Head-Res&DrugSell$59.32K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1-15
2025 Q4-1
2025 Q3-4
2025 Q2-2

IRWD Ownership FAQ


Who Owns Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals shareholders are primarily institutional investors at 98.65%, followed by 2.93% insiders and -1.58% retail investors. The average institutional ownership in Ironwood Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Ironwood Pharmaceuticals exceeds.

Who owns the most shares of Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals’s largest shareholders are Blackrock (22.88M shares, 14.51%), Vanguard group (15.96M shares, 9.84%), and Armistice capital (15.03M shares, 9.26%). Together, they hold 33.61% of Ironwood Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ironwood Pharmaceuticals?

Yes, BlackRock owns 14.51% of Ironwood Pharmaceuticals, totaling 22.88M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 149.16M$. In the last quarter, BlackRock decreased its holdings by -1.281M shares, a -5.30% change.

Who is Ironwood Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sarissa capital management lp is Ironwood Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 20.46% of its assets in 9.19M Ironwood Pharmaceuticals shares, valued at 32.25M$.

Who is the top mutual fund holder of Ironwood Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Ironwood Pharmaceuticals shares, with 5.66% of its total shares outstanding invested in 9.06M Ironwood Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools